Evidence & policy library
Every pathway is linked to the organizations responsible for the decision.
11 source records
Methodology
Pathway information draws on official regulator, HTA and payer materials. Consult the cited policy for its conditions and effective date, and see Content & use for guidance on applying Atlas to your research.
Matching documents: 12
Market / scopeOfficial evidence recordTypePolicy / reference dateLast checked
Americas
🇧🇷 BrazilOfficialregulatory classification/registration; biologics separateRDC 753/2022, RDC 948/2024Latest observed: 2026
🇧🇷 BrazilOfficialcurrent DIP/categories/timing; detailed category tests need legal annexeffective/amended 2026Latest observed: 2026-07-13
🇧🇷 BrazilOfficialPF/PMC/PMVG/ICMS/CAP ceilings, not net procurementmonthly 2026 listLatest observed: 2026
🇧🇷 BrazilOfficialHTA, decision and implementation periodscurrent through 2026-05Latest observed: 2026-05
🇧🇷 BrazilOfficialnational list/funding responsibility; live status neededRENAME 2024 + real timeLatest observed: 2026
🇧🇷 BrazilOfficialgroups/PCDT/LME/state authorizationcurrent 2026Latest observed: 2026
🇧🇷 BrazilOfficialoncology financing distinction; AF-ONCO update separateupdated 2025-12-12Latest observed: 2025-12
🇧🇷 BrazilOfficialoncology component/acquisition plus CNES dilution-centre qualification; implementation evolvingPortaria 8.477/2025 + 2026 amendments; Portaria GM/MS 12.085 dated 2026-08-17Latest observed: official page posted 2026-08-18
🇧🇷 BrazilOfficialprivate mandatory coverage process/DUTupdated 2026-06-30Latest observed: 2026-06
🇧🇷 BrazilOfficialjudicial exception/competence; named case legal advice requiredbinding decisions + 2025 guideLatest observed: 2025-11
🇧🇷 BrazilOfficialformal SEI dossier, NUP and auditable economic models; upload-size conflict and form-channel relationship retainedprocedural instructions; no separate legal commencement assertedLatest observed: CONITEC 2026-09-14; protocol service 2026-09-17
🇧🇷 BrazilOfficialformal SEI dossier, NUP and auditable economic models; upload-size conflict and form-channel relationship retainedprocedural instructions; no separate legal commencement assertedLatest observed: CONITEC 2026-09-14; protocol service 2026-09-17
For education only — not regulatory, pricing or legal advice.